ArticleInternational journal of preventive medicine2026
Diabetes Mellitus in Post-renal Transplant and Nephrotic Syndrome Children on Tacrolimus: (Case Report).
Article in International journal of preventive medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pathogenesis of post-transplant diabetes mellitus (PTDM) in renal transplantation is not well established, but both IR and insulin deficiency are necessary for the appearance of PTDM. β-cell dysfunction is not the only player in the pathogenesis of diabetes; insulin resistance (IR) is also a risk factor for the development of T2DM in the general population. Generally, IR is highly prevalent in renal transplant recipients. Calcineurin inhibitors are still the mainstay of immunosuppression and can decrease insulin release from pancreatic β-cells. Changing tacrolimus to Cyclosporine to improve glucose metabolism in stable renal transplant recipients has been suggested in much of the previous literature. In studies comparing the efficacy of tacrolimus and Ciclosporin in preventing acute rejection and graft loss, tacrolimus has always been superior. However, the majority of studies comparing the two drugs reported higher incidents of PTDM with tacrolimus than Ciclosporin.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.